Sven-Erik Strand
111 – 120 of 184
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Change in Tumor-absorbed Dose due to Decrease in Mass during Fractionated Radioimmunotherapy in Lymphoma Patients.
- Contribution to journal › Article
- 2002
-
Mark
An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I.
- Contribution to journal › Article
-
Mark
A dosimetry model for the small intestine incorporating intestinal wall activity and cross-doses.
- Contribution to journal › Article
-
Mark
FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma.
- Contribution to journal › Article
-
Mark
Time dependence of the activity concentration ratio of red marrow to blood and implications for red marrow dosimetry.
- Contribution to journal › Article
-
Mark
A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.
- Contribution to journal › Article
-
Mark
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
- Contribution to journal › Article
-
Mark
Single tumor cell uptake and dosimetry of technetium-99m Fab ' anti-CD22 in low-grade B-cell lymphoma
- Contribution to journal › Article
-
Mark
Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium-111-HMFG1-biotin.
- Contribution to journal › Article
- 2001
-
Mark
Quantitative Gated SPECT: A Monte Carlo evaluation
- Contribution to journal › Letter
